A study led by Peter Campbell, M.D., M.P.H., indicates artificial intelligence can infer race from images of the retina, which Campbell says suggest additional steps may be needed to prevent racial bias in AI.

Alice Cuprill-Comas, OHSU executive vice president of institutional affairs and general counsel, is recognized by the Portland Business Journal among 2023 business executives of the year.

U.S. News & World Report released its top 15 medical schools for research, which revealed OHSU as No. 1 for family medicine.

In an article about the Oregon bill on abortion and gender-affirming care, KGW-TV cites an OHSU website, which feature frequently asked questions on the topic.

Women.com suggests the benefits of scheduling sex, citing OHSU Center for Women’s Health guidance regarding the benefits of sex in lowering blood pressure, relieving depression, promoting pain relief and improving sleep.

In a story about chronic pain, Cannabis Patient Care cites OHSU evidence review published in 2022 that found thin evidence behind cannabis-related products to treat chronic pain.

Mark Pennesi, M.D., Ph.D., is the lead researcher of an Endogena Therapeutics-sponsored Phase 1/2a clinical trial for a potential treatment for the blindness-causing condition retinitis pigmentosa.

The Lund Report covers unionizing effort by research workers at OHSU.

The Bulletin (Bend) says OHSU’s and St. Charles Health’s joint efforts to establish a new family medicine residency program in Central Oregon beginning in 2024 “needs to be celebrated” because it “aims to help address the critical gap in rural healthcare.”